Paul K. Audhya, Chief Medical Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 2,780 shares at $10.14 ($28K) on 2023-05-18, disclosed to the SEC on 2023-05-19.
Open-market sale of $28k KALV by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KALV | SELL | 2026-05-19 | $28K | — | Filing → |
| KALV | SELL | 2026-04-20 | $54K | — | Filing → |
| KALV | SELL | 2026-02-24 | $167K | — | Filing → |